1Chegini N. The role of growth factors in peritoneal healing:transforming growth factor beta. Eur J Surg( Suppl), 1997,577 (1) :17.
2Evans DM, Mcaree K, Guyton DP, et al. Dose dependency and wound healing aspects of the use of tissue plasminogen activitor in the prevention of intra- abdominal adhesions. Am J Surg,1993,165(7) :2290.
3Holmdah IZ, Risberg B, Beck DE,et al. Adhesions pathogenesis and prevention panel discussion and summary. Eur J Surg (Suppl),1997,577(3) :561.
4Sunds Al - Took, Robert P, Togas T. Adhesion - related smallbowel obstruction after gynecologic operations. Am J Obstet Gynecol,1999.180(2) :313.
5Vipond MN ,Whawell SA ,Thompson JN ,et al. Peritoneal fibrinolytic activity and intra - abdominal adhesions. Lancet, 1990,335 (8698) :1120.
6Holmdah IZ, Al - Jabree M, Risberg B. The role of fibrinolysis in the formation of post - operative adhesions. Wound Bepre, 1994, 27(1) :171.
7Bothin C. Counteracting poetsurgical adhesion : the effect of combining oxidized regenerated cellulose and tissue plasminogen activitor.Int J Fertil,1995,40(2) :102.
2MAcDorman M F, Declercq E, Menacker F, et al.Neonatal mortality for primary cesarean and vaginal births to low-risk women : application of an intention-to-treatmodel[J].Birth, 2008, 35(1l): 3-8.
